Teva Pharmaceutical Industries (TEVA) ordinary shares began trading directly on the New York Stock Exchange, completing its transition from its American depositary shares program, the drugmaker said Monday.
The company said the shares will continue to trade under the ticker "TEVA" on both the NYSE and Tel Aviv Stock Exchange.
Teva said the direct listing is expected to expand investor access and strengthen its position in US capital markets.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.